Category: Blog

Continuous Manufacturing and Semi-Solids

A recent article in Outsourcing Pharma reported on FDA’s CDER Director Janet Woodcock’s testimony to congress on continuous manufacturing for the pharmaceutical industry. Woodcock stated in the hearing that “though making the switch from batch to continuous manufacturing may be difficult, costly and time-consuming, pharma manufacturers and…

The IVRT Outbreak

In vitro release testing (IVRT) for semi-solid dosage forms (e.g. creams, lotions, gels, and ointments) has been around for more than thirty years, first appearing in the literature in the late 1970s and early 1980s.  During the last decade however, we have seen a substantial upsurge…

New FDA Request for Quality Metrics

The FDA has released a draft of its Request for Quality Metrics, a guide for the pharmaceutical industry. The document contains non-binding recommendations, outlines a set of measurements to evaluate the quality of the facilities and the processes that manufacturers use to make regulated drugs and…

Indoor Tanning Rates Decrease in U.S.

According to Healio Dermatology (http://goo.gl/hTYBCy) of a recent article in JAMA Dermatology, people are turning away from indoor tanning. Using National Health Interview Survey data, researchers discovered the drop. According to the article, “Between 2010 and 2013, indoor tanning reduced from 5.5% to 4.2% among…

Copyright © 2019 Tergus Pharma. All Rights Reserved.